Please login to the form below
Germany
This page shows the latest Germany news and features for those working in and with pharma, biotech and healthcare.
Bluebird bio launches beta thalassaemia gene therapy Zynteglo in Germany
As it had previously planned, bluebird has entered into an outcomes-based payment agreement with multiple statutory health insurance providers in Germany. ... Now that bluebird has launched Zynteglo is Germany, the UK will be firmly in its sights.
Latest news
-
GCI Health opens new office in Hong Kong
Icuna. Earlier this year, GCI also expanded into Germany, after it acquired WPP sister agency Hering Schuppener Healthcare.
-
House Democrats finally pass landmark drug pricing bill
the average price levied in six index countries – including Australia, Canada, France, Germany, Japan and the UK.
-
PharmaLex announces joint venture with Vintura
Vintura is a strategy and organisation consultancy with speciality in healthcare and life sciences, and has offices based in Amsterdam, the Netherlands and Munich, Germany.
-
AstraZeneca divests Seroquel rights to focus on key therapy areas
Second divestment to Germany-based Cheplapharm this year. AstraZeneca has sold the commercial rights to schizophrenia and bipolar disorder drugs Seroquel and Seroquel XR to Cheplapharm. .
-
Diurnal files adrenal insufficiency drug Alkindi in US
Alkindi has already been approved in Europe and launched in its first markets – including Germany and the UK – and is specifically designed to allow easier dosing in paediatric patients compared to ... The drug made its debut in Germany in 2018,
More from news
Approximately 44 fully matching, plus 841 partially matching documents found.
Latest Intelligence
-
The 2019 CPhI Pharma Index Report
Union exit and they have seemingly predicted that Germany will be the primary beneficiary of this move. ... In fact, according to Farmaindustria, Italy has equalled Germany in both total production of finished goods and production per unit.
-
Building European biotech firms to rival those of the US
Germany is European biotech’s sleeping giant. “Germany is Europe’s great untapped player in biotech,” said Richard. ... For a number of reasons, such as taxes and red tape, the sector hasn’t really taken off there as much as it could have until
-
European biotech: a new generation of leaders emerges
potential academic researchers across the continent, with a number of specialist venture capital firms and incubators helping to build success stories in the UK, France, Germany, Belgium and Denmark across a ... Morphosys. One of Europe’s star
-
A new EU in the making, what lies ahead for pharma?
The HTA file is in a difficult situation at the moment with Germany and France blocking it. ... For smaller companies however, the stakes are higher. If France, Germany and a few other countries want to support innovation and faster market uptake up to
-
Is anybody listening?
Similarly, authorities in Germany, China, Russia and Australia – as well as the EU in general – are all taking measures to clamp down on companies that aren’t doing enough to fulfil
More from intelligence
Approximately 9 fully matching, plus 124 partially matching documents found.
Latest appointments
-
McCann Health Germany strengthens leadership team
Healthcare communications network McCann Health has made two key appointments to the leadership team of McCann Health Germany. . ... Guido Körfer (pictured above) has been appointed as president of McCann Health Germany.
-
Richard Paulson joins Ipsen as CEO for North America
During a 10-year career at Amgen, Paulson held a number positions at the company, including general manager of Germany and general manager of central and eastern Europe.
-
Dave Lemus joins Proteros as an executive board member
He joins the German biotech’s board from Medigene. Proteros, a private biotech based in Germany, has appointed Dave Lemus as an executive board member, chief operating officer and chief financial
-
MC Services welcomes Dr Claudia Gutjahr-Loeser to its management team
She joins the Duesseldorf, Germany-based firm from MorphoSys, where she headed the corporate communications and investor relations department as senior vice president; a role that saw her took responsibility for
-
Paolo Carli appointed as head of MEA at Merck
He will be responsible for leading commercial operations. Germany's Merck has appointed Paolo Carli as its new head of healthcare business, taking the helm of its commercial operations for the ... Carli joined Merck in 2009 as a member of the mergers and
More from appointments
Approximately 2 fully matching, plus 74 partially matching documents found.
Latest from PMHub
-
Research Partnership opens new office in Lyon, France
She will have a remit to grow and expand the Lyon office as well as to service existing clients based in France, Switzerland and Germany.
-
OPEN Health announces the integration of Pharmerit International into the group
In terms of scale, the integration means OPEN Health will now consist of 700 people in 15 offices across 6 different countries including US, UK, The Netherlands, Germany, India and China.
-
Research Partnership publishes new patient Living with Ankylosing Spondylitis & nr-axSpA EU & US 2019 reports
The AS 5EU report comprises of interviews with 385 patients in France, Germany, Italy, Spain and UK, while the AS US report is based on a study of 136 patients.
-
Cello Health launches ‘Cello Health GmbH’ with new Berlin office and appointment of two regional directors to lead the Business Insights and Analytics division in Germany.
Health Insight Germany, and Matthias Heurich – Regional Director, supporting Digital Innovation. ... Tombrink has been leading small and large teams in and outside of matrix organizations and will function as the country head of Cello Health Insight in
-
Report: Living with RA (EU, Japan and Canada) 2019 reports
Living with Rheumatoid Arthritis (RA) is a quantitative study conducted online amongst 390 patients diagnosed with RA in the 5 EU markets (France, Germany, Italy, Spain, UK) and 55 patients in
More from PMHub
Approximately 1 fully matching, plus 69 partially matching documents found.
Featured jobs
- Account Director or Senior Account Director
-
Salary TBC
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
-
Consultant
-
competitive salary
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
-
Vice President
-
Competitive Salary Offered
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
Subscribe to our email news alerts
PMHub
Branding Science
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...
Latest intelligence
- How do companies prepare for reimbursement?
- Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
- Integrating electronic health records into clinical trials
- How organisations are working to realise the research potential of EHRs...
- Keeping up the fight against HIV and using the lessons to tackle other threats
- Danny Buckland interviews Gilead’s Mike Elliott...
Quick links
Infographics
